- Home
- SUUN vs ICCM Comparison
SUUN vs ICCM Comparison
Compare SUUN & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUUN
- ICCM
- Stock Information
- Founded
- SUUN 2013
- ICCM 2006
- Country
- SUUN Canada
- ICCM Israel
- Employees
- SUUN N/A
- ICCM N/A
- Industry
- SUUN
- ICCM
- Sector
- SUUN
- ICCM
- Exchange
- SUUN Nasdaq
- ICCM Nasdaq
- Market Cap
- SUUN 69.2M
- ICCM 72.4M
- IPO Year
- SUUN N/A
- ICCM N/A
- Fundamental
- Price
- SUUN $2.38
- ICCM $1.20
- Analyst Decision
- SUUN Strong Buy
- ICCM Strong Buy
- Analyst Count
- SUUN 1
- ICCM 2
- Target Price
- SUUN $6.00
- ICCM $2.70
- AVG Volume (30 Days)
- SUUN 34.6K
- ICCM 441.2K
- Earning Date
- SUUN 02-14-2025
- ICCM 11-26-2024
- Dividend Yield
- SUUN N/A
- ICCM N/A
- EPS Growth
- SUUN N/A
- ICCM N/A
- EPS
- SUUN N/A
- ICCM N/A
- Revenue
- SUUN $49,373,547.00
- ICCM $3,671,000.00
- Revenue This Year
- SUUN $30.37
- ICCM $10.03
- Revenue Next Year
- SUUN $21.11
- ICCM $62.68
- P/E Ratio
- SUUN N/A
- ICCM N/A
- Revenue Growth
- SUUN 223.82
- ICCM 26.02
- 52 Week Low
- SUUN $1.95
- ICCM $0.48
- 52 Week High
- SUUN $7.50
- ICCM $1.57
- Technical
- Relative Strength Index (RSI)
- SUUN 55.55
- ICCM 60.15
- Support Level
- SUUN $1.99
- ICCM $1.16
- Resistance Level
- SUUN $2.55
- ICCM $1.27
- Average True Range (ATR)
- SUUN 0.19
- ICCM 0.10
- MACD
- SUUN 0.05
- ICCM -0.02
- Stochastic Oscillator
- SUUN 57.87
- ICCM 41.64
About SUUN SolarBank Corporation Common Stock
SolarBank Corp is an independent renewable and clean energy project developer and asset operator based in Canada and the United States. It is engaged in the development and operation of solar photovoltaic power generation projects in the province of Ontario and the state of New York. The company operates in two principal geographical areas - Canada and United States with a substantial portion of its overall revenue being generated from United States.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.